Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)

This study has suspended participant recruitment.
Sponsor:
Information provided by:
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00065572
First received: July 28, 2003
Last updated: January 25, 2011
Last verified: January 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: February 2004
  Estimated Primary Completion Date: February 2004 (Final data collection date for primary outcome measure)